COMPARISON OF PREDICTIVE VALUE OF RISK SCORES REGARDING THE SHORT-TERM AND LONG-TERM PROGNOSIS OF PATIENTS WITH ACUTE MYOCARDIAL INFARCTION TREATED WITH PRIMARY PERCUTANEOUS CORONARY INTERVENTION
Abstract
Introduction: Primary percutaneous coronary intervention (pPCI) presents standard treatment in patients with acute myocardial infarction. In order to predict the prognosis of patients with ST segment elevation myocardial infarction (STEMI), several risks scores risk have been developed.
Aim: We aimed to compare the predictive value of three validated risk scores, regarding intrahospital, short-term (30-days) and long-term (1-year) mortality among patients with a diagnosis of STEMI treated with pPCI in the Catheterization lab, Clinical Center of Serbia.
Material and methods: This retrospective study included 311 consecutive patients with a diagnosis of STEMI treated with pPCI in 2017. Patients with cardiogenic shock at admission were excluded. Data were analyzed from the electronic database. For every patient the value of CADILLAC, ZWOLLE and TIMI score was calculated. The predictive ability of the risk scores was compared by area under (AUC) the ROC (Receiver Operating Characteristic) curves. The short-term and long-term outcome of the patient was assessed by telephone and clinical contact.
Results: The study population was 311 patients, with an average age of 61±10 years, of which 237 (76.2%) were male. Rates of intrahospital, mortality at 30 days and at one year after pPCI were 1.9%, 3.2%, 6.1%. All three test scores showed very good predictive value in predicting short-term mortality, both intrahospital (0.962; 0.986; 0.964, p=ns within scores) and after 30 days (0.920; 0.956; 0.861, p=ns within scores), while after 1 year accuracy of CADILLAC and ZWOLLE was better than TIMI score (0.921; 0.905; 0.786, p vs. TIMI 0,0087 and 0,0567). Age, three vessel coronary disease and lower admission hemoglobin were identified as independent predictors for one-year mortality by logistic regression analysis.
Conclusion: CADILLAC and ZWOLLE showed very good predictive ability for intrahospital, short and long-term mortality, while for TIMI score, comparable accuracy was observed only for a period up to 30 days following pPCI.
Key words: acute myocardial infarction, STEMI, primary PCI, risk assessment
References
2. Littnerova S, Kala P, Jarkovsky J, et al. GRACE Score among Six Risk Scoring Systems (CADILLAC, PAMI, TIMI Dynamic TIMI, Zwolle) Demonstrated the Best Predictive Value for Prediction of Long-Term Mortality in Patients with ST-Elevation Myocardial Infarction. PLoS One. 2015; 10(4).
3. Widimsky P, Wijns W, Fajadet J, et al. Reperfusion therapy for ST-Elevation Myocardial Infarction in Europe: description of the current situation in 30 countries. Eur Heart J. 2010; 31(8):943-957.
4. Filipiak KJ, Kotlowski L, Grabowski M, et al. Comparison of the 7-year predictive value of six risk scores in acute coronary syndrome patients: GRACE, TIMI STEMI, TIMI NSTEMI, SIMPLE, ZWOLLE and BANACH. Kardiol Pol. 2014; 72(2):155-165.
5. Steg GP, James SK, Atar D, et al. ESC Guidelines for the management of acute myocardial infarction in patients presenting with ST-segment elevation: Task Force on the management of ST-segment elevation acute myocardial infarction of the European Society of Cardiology (ESC). Eur Heart J. 2012; 33(20):2569-2619.
6. Morrow DA, Antman EM, Charlesworth A, et al. TIMI risk score for ST-Elevation Myocardial Infarction: A Convenient, Bedside, Clinical Score for Risk Assessment at Presentation An Intravenous nPA for Treatment of Infarcting Myocardium Early II Trial Substudy. Circulation. 2000; 102(17):2031-2037.
7. Kozieradzka A, Kaminski KA, Maciorkowska D, et al. GRACE, TIMI, Zwolle and CADILLAC risk scores/Do they predict 5-year outcomes after ST-elevation myocardial infarction treated invasively?. International J of Cardiology. 2011; 148(1):70-75.
8. Morrow DA, Antman EM, Parsons L, et al. Application of the TIMI risk score for ST-elevation MI in the National Registry of Myocardial Infarction 3. JAMA. 2001; 286(11):1356-1359.
9. De Luca G, Surapranata H, van`t Hof AWJ, et al. Prognostic assessment of patients with acute myocardial infarction treated with primary angioplasty: implications for early discharge. Circulation. 2004; 109(22):2737-2743.
10. Lev El, Kornowski R, Vaknin-Assa H, et al. Comparison of the predictive value of four different risk scores for outcomes of patients with ST-elevation acute myocardial infarction undergoing primary percutaneous coronary intervention. Am J Cardiol. 2008;102(1):6-11.
11. Bolinska S, Sobkowicz B, Zaniewska J, et al. The significance of anemia in patients with acute ST-elevation myocardial infarction undergoing primary percutaneous coronary intervention. Kardiol Pol. 2011; 69(1):33-39.
12. Most AS, Ruocco NA, Gewirtz H. Effect of a reduction in blood viscosity on maximal myocardial oxygen delivery distal to a moderate coronary stenosis. Circulation. 1986; 74(5):1085-1092.
13. Braunwald E. Control of myocardial oxygen consumption: physiologic and clinical considerations. Am J Cardiol. 1971; 27(4):416-432.
14. Yamada DM, Topol EJ. Importance of microembolization and inflammation in atherosclerotic heart disease. Am Heart J. 2000; 140(6):90-102.
15. Newell MC, Henry JT, Henry TD, et al. Impact of age on treatment and outcomes in ST-elevation myocardial infarction. Am Heart J. 2011; 161(4):664–672.
16. Angeli F, Verdecchia P, Savonitto S, Morici N, De Servi S, Cavallini C. Early invasive versus selectively invasive strategy in patients with non-ST-segment elevation acute coronary syndrome: impact of age. Catheter Cardiovasc Interv. 2014; 83(5):686–701.